The Zenith Drugs IPO has begun on 19-February-2024. It will close on 22-February-2024. The Total IPO Size is 40.68 Crores. The company set its IPO price is 79 Rs Per Share. Basically, There are three basic categories in Zenith Drugs IPO Subscription 1) QIB 2) Retail Individual Investors (RIIs) 3) NII.
Zenith Drugsare a pharmaceutical manufacturing and trading company based out from Indore.
The company is in the process of setting up a new manufacturing facility in Village Muradpura, Depalpur, Indore, Madhya Pradesh.
Zenith engages in third-party manufacturing, also known as white label manufacturing, for esteemed pharma companies such as Ajanta Pharma, Bio Medical Laboratories, Zest Pharma, and many others.
The global footprint extends to countries such as 1. Costa Rica in Central America and the Caribbean and Pacific regions, 2. Malawi, Mauritius, Mozambique, Sudan, and Tanzania. 3. Bhutan and Cambodia in Southeast Asia, 4. Tajikistan in the CIS region, and
5. Liberia, Sierra Leone, and Conakry in FWA.
Zenith offers a wide range of formulations in various forms such as:
a) Gas Pipeline Projects
b) Liquid Orals
c) Ointments
d) Liquid Externals
e) Capsules
Check :- Upcoming SME IPO 2024
Zenith Drugs IPO Promotor Holding
Mr. Sandeep Bhardwaj, Mr. Bhupesh Soni and Mr. Ajay Singh Dassundi are the promoters of the company.
Zenith Drugs IPO Date, Details & Price Band
| IPO Opening Dates | 19-February-2024 |
| IPO Closing Dates | 22-February-2024 |
| Price Band | 75-79 Rs |
| Fresh Issue | 40.68 Crore |
| Total IPO size | 40.68 Crore |
| Minimum bid (lot size) | 1600 Shares |
| Face Value | 10 INR Per Share |
| Listing On | NSE SME |
Zenith Drugs IPO Market Lot
The Zenith Drugs IPO minimum market lot is 1600 shares With 126,400 ₹ Amount per application.
| Lot | No of Shares | Amount | |
| Minimum | 1 | 1600 | 126,400 Rs |
| Maximum | 1 | 1600 | 126,400 Rs |
| S-HNI (Min) | 2 | 3200 | 252,800 Rs |
Restated Financial Record of the three year (Amt. in Lakhs)
| Total Assets | Total Revenue | Profit After Tax | |
| 31-Mar-23 | 9,793.83 | 11,569.65 | 515.29 |
| 31-Mar-22 | 6,858.47 | 9,266.63 | 312.86 |
Zenith Drugs IPO GMP Grey Market Premium
Zenith Drugs IPO GMP Grey market premium has been started today. Check Latest Zenith Drugs IPO GMP Grey market premium, Kostak Rates and Subject to Sauda Price here.
Zenith Drugs IPO Prospectus
| DRHP | Download |
| RHP | Download |
Zenith Drugs IPO Reviews
IPOWala – Update Soon
Zenith Drugs IPO Form Download
Zenith Drugs IPO is available on NSE Website as well as on our Portal. Please click here Zenith Drugs IPO form Download.
Zenith Drugs IPO Allotment Date & Details
| Allotment Date | 23-February-2024 |
| Initiation of refunds | 26-February-2024 |
| Transfer of shares to Demat accounts | 26-February-2024 |
| Listing Date | 27-February-2024 |
| Check Allotment Status | Click here |
Registrar of Zenith Drugs IPO
BIGSHARE SERVICES PRIVATE LIMITED
S6-2, 6th Pinnacle Business Park, Mahakali Caves Road, next to Ahura Centre, Andheri
East, Mumbai- 400093, Maharashtra, India
Tel No.: +91 – 22 – 6263 8200; Fax No.: +91 – 22 – 6263 8299
E-mail: [email protected]
Investor Grievance E-mail: [email protected]
Website: www.bigshareonline.com
Contact Person: Mr. Asif Sayyed
SEBI Registration No.: INR000001385
Zenith Drugs Contact Details
Zenith Drugs Limited
K. No. 72 / 5, Village Muradpura
NA Depalpur,
Indore-453001
Phone: +91 8435501867
Email: [email protected]
Website: https://zenithdrugs.com/
Zenith Drugs IPO Lead Managers
GRETEX CORPORATE SERVICES LIMITED
Office No. 13, 1st Floor, New Bansilal Building, Raja Bahadur Mansion, 9-15, Homi Modi
Street, Fort, Mumbai– 400001, Maharashtra, India.
Tel No.: +91 96532 49863
Email: [email protected]
Website: www.gretexcorporate.com
Contact Person: Ms. Dimple Magharam Slun
SEBI Registration No: INM000012177
CIN: L74999MH2008PLC288128